The Global Viral Clearance Service Market Report is equipped with market data from 2014 to 2024. The report gives a market overview covering key drivers and risks factors. The report is bifurcated by top global manufactures mentioning sales, revenue and prices as applicable. It also evaluates the competitive scenario of the leading players. The report expands to cover regional market data along with type and application. The report forecasts sales and revenue from 2019 to 2024. The detailed sales channel is also covered in the study.
Viral clearance services refer to viral removal or viral inactivation service. Viral clearance studies are a critical element toward ensuring that an acceptable level of viral safety has been achieved for biological products. The goal of these studies is to demonstrate that the manufacturing purification process has the ability to inactivate and/or remove viruses that are known to contaminate or which may possibly contaminate the starting materials, as well as additional viruses that are models for a broad variety of viruses. Viral clearance studies provide a complementary strategy to direct testing of cell banks, raw materials and bioreactor harvests, which may not detect all viruses that could potentially contaminate the product.
Scope of the Report:
The market for Viral Clearance Service is fragmented with players such as Charles River, , BioReliance (Merck), Eurofins Scientific, Sartorius, Covance, ViruSure, Texcell, Bioscience Labs, Vironova Biosafety, Mérieux NutriSciences, WuXi AppTec, Syngene, Labor Dr. Merkare the global leading suppliers. Top three players occupy for over 39.43% market share in 2017.
The global Viral Clearance Service market is valued at 230 million USD in 2018 and is expected to reach 560 million USD by the end of 2024, growing at a CAGR of 20.1% between 2019 and 2024.
The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.
North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Viral Clearance Service.
Europe also play important roles in global market, with market size of xx million USD in 2019 and will be xx million USD in 2024, with a CAGR of xx%.
This report studies the Viral Clearance Service market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Viral Clearance Service market by product type and applications/end industries.
Market Segment by Companies, this report covers
- Charles River
- BioReliance (Merck)
- Eurofins Scientific
- Sartorius
- Covance
- ViruSure
- Texcell
- Bioscience Labs
- Vironova Biosafety
- Mérieux NutriSciences
- WuXi AppTec
- Syngene
- Labor Dr. Merk
Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
- Basic Service
- Enhanced Service
- Full Service
- Turnkey Service
Market Segment by Applications, can be divided into
- Research Institution
- Pharmaceutical Industry
- Others